{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:49Z","timestamp":1707524629821},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,4]]},"DOI":"10.7759\/cureus.24725","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T15:07:38Z","timestamp":1651676858000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Presentation of Multiple Myeloma: A 71-Year-Old Female With a Single Lytic Lesion of Her Appendicular Skeleton"],"prefix":"10.7759","author":[{"given":"Ahamed","family":"Khalyfa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra C","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yhana","family":"Chavis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: every year a new standard?","volume":"37 Suppl 1","author":"Rajkumar SV","year":"2019","unstructured":"Rajkumar SV. Multiple myeloma: every year a new standard?. Hematol Oncol. 2019, 37 Suppl 1:62-5. 10.1002\/hon.2586","journal-title":"Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian D","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016, 43:676-81. 10.1053\/j.seminoncol.2016.11.004","journal-title":"Semin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren O","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, et al.. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009, 113:5412-7. 10.1182\/blood-2008-12-194241","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss BM","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood. 2009, 113:5418-22. 10.1182\/blood-2008-12-195008","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton LJ 3rd","year":"2005","unstructured":"Melton LJ 3rd, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res. 2005, 20:487-93. 10.1359\/JBMR.041131","journal-title":"J Bone Miner Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:e538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322006000400007","article-title":"Prognostic factors in pathologic fractures secondary to metastatic tumors","volume":"61","author":"Narazaki DK","year":"2006","unstructured":"Narazaki DK, de Alverga Neto CC, Baptista AM, Caiero MT, de Camargo OP. Prognostic factors in pathologic fractures secondary to metastatic tumors. Clinics (Sao Paulo). 2006, 61:313-20. 10.1590\/s1807-59322006000400007","journal-title":"Clinics (Sao Paulo)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.080","article-title":"Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma","volume":"10","author":"Talamo G","year":"2010","unstructured":"Talamo G, Farooq U, Zangari M, Liao J, Dolloff NG, Loughran TP Jr, Epner E. Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma. Clin Lymphoma Myeloma Leuk. 2010, 10:464-8. 10.3816\/CLML.2010.n.080","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2013.04.001","article-title":"Myeloma bone disease: pathophysiology and management","volume":"2","author":"Silbermann R","year":"2013","unstructured":"Silbermann R, Roodman GD. Myeloma bone disease: pathophysiology and management. J Bone Oncol. 2013, 2:59-69. 10.1016\/j.jbo.2013.04.001","journal-title":"J Bone Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-0974-x","article-title":"Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications","volume":"60","author":"Terpos E","year":"2011","unstructured":"Terpos E, Dimopoulos MA. Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications. Cancer Immunol Immunother. 2011, 60:305-17. 10.1007\/s00262-011-0974-x","journal-title":"Cancer Immunol Immunother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2022","article-title":"PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression","volume":"29","author":"Cafforio P","year":"2014","unstructured":"Cafforio P, Savonarola A, Stucci S, et al.. PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. J Bone Miner Res. 2014, 29:55-66. 10.1002\/jbmr.2022","journal-title":"J Bone Miner Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1190","article-title":"Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells","volume":"100","author":"Standal T","year":"2002","unstructured":"Standal T, Seidel C, Hjertner \u00d8, et al.. Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. Blood. 2002, 100:3002-7. 10.1182\/blood-2002-04-1190","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85775-an-unusual-presentation-of-multiple-myeloma-a-71-year-old-female-with-a-single-lytic-lesion-of-her-appendicular-skeleton","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:27Z","timestamp":1707507687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85775-an-unusual-presentation-of-multiple-myeloma-a-71-year-old-female-with-a-single-lytic-lesion-of-her-appendicular-skeleton"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.24725","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,4]]}}}